Published in J Neurooncol on April 06, 2006
Interlaced x-ray microplanar beams: a radiosurgery approach with clinical potential. Proc Natl Acad Sci U S A (2006) 1.21
Microbeam radiosurgery using synchrotron-generated submillimetric beams: a new tool for the treatment of brain disorders. Neurosurg Rev (2010) 0.95
Microbeam radiation therapy alters vascular architecture and tumor oxygenation and is enhanced by a galectin-1 targeted anti-angiogenic peptide. Radiat Res (2012) 0.90
Survival analysis of F98 glioma rat cells following minibeam or broad-beam synchrotron radiation therapy. Radiat Oncol (2011) 0.89
A narrow microbeam is more effective for tumor growth suppression than a wide microbeam: an in vivo study using implanted human glioma cells. J Synchrotron Radiat (2011) 0.89
Synchrotron-generated microbeam sensorimotor cortex transections induce seizure control without disruption of neurological functions. PLoS One (2013) 0.86
Image-guided microbeam irradiation to brain tumour bearing mice using a carbon nanotube x-ray source array. Phys Med Biol (2014) 0.85
Interactions between synchrotron radiation X-ray and biological tissues - theoretical and clinical significance. Int J Physiol Pathophysiol Pharmacol (2011) 0.82
NAD(+) administration significantly attenuates synchrotron radiation X-ray-induced DNA damage and structural alterations of rodent testes. Int J Physiol Pathophysiol Pharmacol (2012) 0.82
Biodosimetric quantification of short-term synchrotron microbeam versus broad-beam radiation damage to mouse skin using a dermatopathological scoring system. Br J Radiol (2011) 0.82
Roles of oxidative stress in synchrotron radiation X-ray-induced testicular damage of rodents. Int J Physiol Pathophysiol Pharmacol (2012) 0.80
DNA damage and repair kinetics after microbeam radiation therapy emulation in living cells using monoenergetic synchrotron X-ray microbeams. J Synchrotron Radiat (2011) 0.79
Roles of NAD (+) , PARP-1, and Sirtuins in Cell Death, Ischemic Brain Injury, and Synchrotron Radiation X-Ray-Induced Tissue Injury. Scientifica (Cairo) (2013) 0.77
Dose-rate plays a significant role in synchrotron radiation X-ray-induced damage of rodent testes. Int J Physiol Pathophysiol Pharmacol (2016) 0.75
Sparing of tissue by using micro-slit-beam radiation therapy reduces neurotoxicity compared with broad-beam radiation therapy. J Radiat Res (2016) 0.75
Generation of low-flux X-ray micro-planar beams and their biological effect on a murine subcutaneous tumor model. J Radiat Res (2015) 0.75
Gold nanoparticles: a new X-ray contrast agent. Br J Radiol (2006) 6.31
Morphological clues to wet granular pile stability. Nat Mater (2008) 2.47
Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med (2001) 2.41
Prospects for microbeam radiation therapy of brain tumours in children to reduce neurological sequelae. Dev Med Child Neurol (2007) 2.29
High-resolution brain tumor visualization using three-dimensional x-ray phase contrast tomography. Phys Med Biol (2007) 2.09
Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol (1994) 2.04
Low versus high cell turnover in diffusely growing non-Hodgkin's lymphomas. J Pathol (1995) 2.03
BCA-1 is highly expressed in Helicobacter pylori-induced mucosa-associated lymphoid tissue and gastric lymphoma. J Clin Invest (1999) 1.94
Atypical pulmonary thrombosis caused by a toxic cyanobacterial peptide. Science (1983) 1.86
The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization. Med Phys (1995) 1.75
Altered apoptotic profiles in irradiated patients with increased toxicity. Int J Radiat Oncol Biol Phys (1999) 1.73
Low-dose phase contrast x-ray medical imaging. Phys Med Biol (1998) 1.65
Mammography with synchrotron radiation: phase-detection techniques. Radiology (2000) 1.55
Manic syndrome early and late in the course of HIV. Am J Psychiatry (1993) 1.54
Differential in situ expression of the genes encoding the chemokines MCP-1 and RANTES in human inflammatory bowel disease. J Pathol (1996) 1.52
Region-of-interest tomography for grating-based X-ray differential phase-contrast imaging. Phys Rev Lett (2008) 1.51
Improved dose concept for radioiodine therapy of multifocal and disseminated functional thyroid autonomy. Eur J Endocrinol (1995) 1.45
Clinical significance of human intestinal spirochetosis--a morphologic approach. Infection (2003) 1.41
A novel tracking technique for the continuous precise measurement of tumour positions in conformal radiotherapy. Phys Med Biol (2000) 1.39
Neuropathology of ablation of rat gliosarcomas and contiguous brain tissues using a microplanar beam of synchrotron-wiggler-generated X rays. Int J Cancer (1998) 1.37
Distribution and fate of ingested carbon particles in mice. J Reticuloendothel Soc (1978) 1.36
Micro-CT enables microlocalisation and quantification of Her2-targeted gold nanoparticles within tumour regions. Br J Radiol (2010) 1.36
Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin. Cancer Res (2000) 1.29
Substance-P receptors in human primary neoplasms: tumoral and vascular localization. Int J Cancer (1995) 1.28
Subacute neuropathological effects of microplanar beams of x-rays from a synchrotron wiggler. Proc Natl Acad Sci U S A (1995) 1.26
Feasibility of noninvasive analysis of lead in the human tibia by soft x-ray fluorescence. Med Phys (1983) 1.25
Effects of respiratory motion on dose uniformity with a charged particle scanning method. Phys Med Biol (1992) 1.16
Imaging lobular breast carcinoma: comparison of synchrotron radiation DEI-CT technique with clinical CT, mammography and histology. Phys Med Biol (2004) 1.16
Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathol (1996) 1.12
[Significance of autopsy. Continuous evaluation of autopsy findings by internists]. Schweiz Med Wochenschr (1986) 1.12
Accumulation of 2-micron latex particles in mouse Peyer's patches during chronic latex feeding. Experientia (1978) 1.09
Effects of pulsed, spatially fractionated, microscopic synchrotron X-ray beams on normal and tumoral brain tissue. Mutat Res (2009) 1.09
Fate of thymocytes: studies with 125I-iododeoxyuridine and 3H-thymidine in mice. Cell Tissue Kinet (1977) 1.07
High-resolution breast tomography at high energy: a feasibility study of phase contrast imaging on a whole breast. Phys Med Biol (2012) 1.05
Analytical and experimental determination of signal-to-noise ratio and figure of merit in three phase-contrast imaging techniques. Opt Express (2012) 1.04
Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters. Oncogene (2008) 1.03
Human endolymphatic sac: evidence for a role in inner ear immune defence. ORL J Otorhinolaryngol Relat Spec (1990) 1.02
Abortion in woman caused by caprine Chlamydophila abortus (Chlamydia psittaci serovar 1). Swiss Med Wkly (2002) 1.01
L-line x-ray fluorescence of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: public health implications. Proc Natl Acad Sci U S A (1989) 1.01
Determination of dosimetrical quantities used in microbeam radiation therapy (MRT) with Monte Carlo simulations. Med Phys (2006) 1.01
Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol Sci (1995) 1.00
In vivo measurement of cortical bone lead using polarized x rays. Med Phys (1989) 0.99
Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys (2001) 0.99
Radiosurgical palliation of aggressive murine SCCVII squamous cell carcinomas using synchrotron-generated X-ray microbeams. Br J Radiol (2006) 0.99
Evaluation of the minimum iodine concentration for contrast-enhanced subtraction mammography. Phys Med Biol (2006) 0.99
Sequential measurements of bone lead content by L X-ray fluorescence in CaNa2EDTA-treated lead-toxic children. Environ Health Perspect (1991) 0.98
Neurotensin receptors in human neoplasms: high incidence in Ewing's sarcomas. Int J Cancer (1999) 0.97
New technology enables high precision multislit collimators for microbeam radiation therapy. Rev Sci Instrum (2009) 0.97
Glomerulonephritis in a patient with complement factor I deficiency. Am J Kidney Dis (1999) 0.96
X-ray phase-contrast imaging with nanoradian angular resolution. Phys Rev Lett (2013) 0.96
Inhibition of submandibular and lacrimal gland infiltration in nonobese diabetic mice by transgenic expression of soluble TNF-receptor p55. J Clin Invest (1996) 0.96
Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism (1996) 0.96
On the implementation of computed laminography using synchrotron radiation. Rev Sci Instrum (2011) 0.94
Single-and dual-energy CT with monochromatic synchrotron x-rays. Phys Med Biol (1997) 0.94
MOSFET dosimetry for microbeam radiation therapy at the European Synchrotron Radiation Facility. Med Phys (2003) 0.93
Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res (1996) 0.93
In vitro autoradiographic and in vivo scintigraphic localization of somatostatin receptors in human lymphatic tissue. Blood (1993) 0.92
Theoretical comparison of three X-ray phase-contrast imaging techniques: propagation-based imaging, analyzer-based imaging and grating interferometry. Opt Express (2012) 0.92
SDZ PSC 833, a non-immunosuppressive cyclosporine: its potency in overcoming P-glycoprotein-mediated multidrug resistance of murine leukemia. Int J Cancer (1992) 0.92
Immunohistochemical detection of somatostatin sst2a receptors in the lymphatic, smooth muscular, and peripheral nervous systems of the human gastrointestinal tract: facts and artifacts. J Clin Endocrinol Metab (1999) 0.92
New irradiation geometry for microbeam radiation therapy. Phys Med Biol (2005) 0.92
Biodistribution of boronophenylalanine in patients with glioblastoma multiforme: boron concentration correlates with tumor cellularity. Radiat Res (1998) 0.91
A simplified approach for computed tomography with an X-ray grating interferometer. Opt Express (2011) 0.91
Boron neutron capture therapy of intracerebral rat gliosarcomas. Proc Natl Acad Sci U S A (1990) 0.91
Intestinal vessels express a high density of somatostatin receptors in human inflammatory bowel disease. Gastroenterology (1994) 0.91
Familial chordoma with probable autosomal dominant inheritance. Am J Med Genet (1998) 0.90
In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer (1992) 0.90
"Neuroendocrine" differentiation in hepatocellular carcinomas (HCCs): immunohistochemical reactivity is related to distinct tumor cell types, but not to tumor grade. Histol Histopathol (1993) 0.89
Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine. Radiat Res (1992) 0.89
Qualitative evaluation of titanium implant integration into bone by diffraction enhanced imaging. Phys Med Biol (2006) 0.89
Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. J Clin Endocrinol Metab (2000) 0.88
Boron neutron capture therapy of a murine mammary carcinoma using a lipophilic carboranyltetraphenylporphyrin. Radiat Res (2001) 0.88
Physics study of microbeam radiation therapy with PSI-version of Monte Carlo code GEANT as a new computational tool. Med Phys (2000) 0.88
Receptor autoradiographic evaluation of cholecystokinin, neurotensin, somatostatin and vasoactive intestinal peptide receptors in gastro-intestinal adenocarcinoma samples: where are they really located? Int J Cancer (1999) 0.88
The value of octreotide scintigraphy in patients with lung cancer. Eur J Nucl Med (1994) 0.88
Metastatic hormone-refractory prostatic adenocarcinoma expresses somatostatin receptors and is visualized in vivo by [111In]-labeled DTPA-D-[Phe1]-octreotide scintigraphy. Cancer Res (1995) 0.88
Research at the European Synchrotron Radiation Facility medical beamline. Cell Mol Biol (Noisy-le-grand) (2000) 0.88